Depressive Disorders - Benelux | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$298.90m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.83%, resulting in a market volume of US$311.50m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$201.10 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Benelux is experiencing steady growth due to increasing customer preferences for mental health treatments and therapies.

Customer preferences: Customers in Benelux are increasingly seeking treatment for depressive disorders, leading to a growing demand for medications and therapies. This can be attributed to a greater awareness and understanding of mental health issues, as well as reduced stigma surrounding seeking help for mental health conditions. Customers are actively seeking out healthcare professionals who specialize in mental health, and are willing to invest in treatments that can improve their quality of life.

Trends in the market: One of the key trends in the Depressive Disorders market in Benelux is the shift towards personalized medicine. Healthcare providers are increasingly tailoring treatment plans to individual patients, taking into account their specific symptoms, medical history, and genetic factors. This trend is driven by advancements in genetic testing and the growing understanding of the genetic basis of depressive disorders. Personalized medicine allows for more targeted and effective treatments, leading to better outcomes for patients.Another trend in the market is the increasing use of digital health solutions. Benelux has a high level of internet penetration and a tech-savvy population, making it an ideal market for digital health innovations. These solutions include mobile apps, online therapy platforms, and wearable devices that can help individuals manage their depressive symptoms. The convenience and accessibility of these digital solutions are driving their adoption among customers in Benelux.

Local special circumstances: Benelux countries have well-established healthcare systems that prioritize mental health. The governments in these countries have implemented policies and initiatives to improve access to mental health services and reduce the stigma associated with mental illnesses. This supportive environment has contributed to the growth of the Depressive Disorders market in Benelux, as individuals feel more comfortable seeking help and treatment.

Underlying macroeconomic factors: The Depressive Disorders market in Benelux is also influenced by underlying macroeconomic factors. The region has a stable and prosperous economy, which allows individuals to afford the cost of mental health treatments and therapies. Additionally, the high level of education and awareness in Benelux countries contributes to the demand for mental health services, as individuals are more likely to recognize and seek help for depressive disorders.In conclusion, the Depressive Disorders market in Benelux is experiencing growth due to increasing customer preferences for mental health treatments and therapies. The shift towards personalized medicine and the adoption of digital health solutions are key trends in the market. The supportive healthcare environment and stable macroeconomic factors in Benelux further contribute to the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.